Remote Patient Monitoring Market Size & Share, by Monitoring Type (Multi-Parameter, Blood Glucose, Respiratory, Cardiac Monitoring); Type (Wireless, Wired); Component (Devices, Software); Indication (Oncology, Diabetes, Hypertension, COPD, Congestive Heart Failure); End-user (Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 2443
  • Published Date: Feb 08, 2023
  • Report Format: PDF, PPT

Companies Dominating the Remote Patient Monitoring Landscape

top-features-companies
    • F. Hoffmann-La Roche Ltd
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Koninklijke Philips N.V.
    • Abbott Laboratories
    • Bio Telemetry, Inc.
    • Boston Scientific Corporation
    • Omron Corporation
    • Masimo Corporation
    • Edward Lifesciences Corporation
    • Nihon Kohden Corporation
    • Medtronic plc

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • F. Hoffmann-La Roche Ltd to unveil a digital PCR system, Digital LightCycler System. It is a next-generation PCR system that has been developed for assisting the clinical researcher to understand the type of cancer and if it is associated with an infection or genetic disease.

  • Bio Telemetry, Inc. to complete its acquisition of On.Demand remote patient monitoring (RPM) and coaching platforms. The platform is mainly functioned by Envolve People Care, Inc. The acquisition took place to enhance the quality of life and decrease the cost of care.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 2443
  • Published Date: Feb 08, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing cases of cardiovascular diseases and rising prevalence of diabetes across the globe are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2023-2033.

A significant need for higher initial investment and higher costs associated with the procedure is estimated to challenge the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Koninklijke Philips N.V., Abbott Laboratories, Bio Telemetry, Inc., Boston Scientific Corporation, Omron Corporation, Masimo Corporation, Edward Lifesciences Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by monitoring type, type, component, indication, end-user, and by region.

The oncology segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying